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Clinical trials are expensive. Understanding where a trial
is needed and what questions to address is therefore
important. We ask if pilot work using observational
healthcare data can be used to inform a trial.
Symptoms of significant psychological distress are
common in cancer patients but are often left untreated.
It is unknown to what extent such distress symptoms
persist over time and require treatment. Should a clini-
cal trial be devised to determine if patients would bene-
fit from treatment? How many and what patients are
likely to suffer from persistent distress and to require
treatment? On what criteria should patients be included
in a trial, and when should trial outcomes be evaluated?
We address these questions using repeated, psycholo-
gical symptom data that were routinely collected from
over 20,000 outpatients who attended selected oncology
clinics in Scotland. However, the limitations to routinely
collected observational healthcare data are many. We
approach the analysis within a missing data context and
develop a Bayesian model in WinBUGS to estimate the
posterior predictive distribution for the incomplete long-
itudinal responses and covariates under both MAR and
MNAR mechanisms and use this model to generate
multiply imputed datasets for analysis in SAS. The find-
ings are compared with those from a purpose-designed,
prospective, clinical study in the same population.
Meaningful analysis of observational healthcare data
requires subject-matter knowledge, good quality data and
appropriate statistical methods. With flexible modelling
techniques now more practicable, we believe pilot work
with such data could help inform future trial designs.
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